TheBodyPro interview
Cytomegalovirus (CMV) is nearly universally present within people living with HIV. It persists despite suppressive antiretroviral therapy, driving chronic immune activation and accelerated biological aging. Clinician-researcher Peter Hunt, M.D., hopes that widespread CMV treatment may prove to have benefits in terms of frailty, cardiovascular disease, cognitive decline, and other aging-related disorders. In a recent interview with TheBodyPro, he explained the science behind this aspiration.
Hunt is a professor of medicine at the University of California-San Francisco. His translational research program seeks to understand the causes and consequences of persistent immune activation and its impact on aging-associated multi-morbidity and mortality in people living with HIV.
Read the full interview here.
Source : TheBodyPro
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.